Add BrightSurf on Google Email

Science News Archive 2005 - Page 131


Page 131 of 165

Harvard, Texas A&M scientists develop new laser

Researchers have created a novel Raman laser that combines the pump source and material into a single device, enhancing efficiency by 30% and reducing size. The 'matryoshka' design enables tuning of the pump laser radiation to strong electronic resonance in the material, boosting gain by five orders of magnitude.

SourceTexas A&M University·JournalNature·DateMar 23, 2005

From gene discovery to preventing eye disease in retinitis pigmentosa

Researchers find that moderate light exposure causes complete retinal degeneration within a month, but lower levels cause slower and reversible damage. This study provides new insights into the interaction of genetics and environment in causing eye disease and suggests potential treatments for preventing blindness.

SourceUniversity of Pennsylvania School of Medicine·JournalProceedings of the National Academy of Sciences·DateMar 22, 2005

Study supports use of aspirin in treating pregnancy disorder

A new study published in the Journal of Clinical Investigation suggests that low-dose aspirin therapy may be a viable treatment option for pre-eclampsia during pregnancy. The research team created a mouse model that mimics low-dose aspirin therapy and found no significant complications, paving the way for further treatment options.

SourceQueen's University·JournalJournal of Clinical Investigation·DateMar 21, 2005

The Bacteria's guide to survival

Researchers discovered that bacteria's pili induce changes in host gene expression, keeping host cells alive longer. The study found that artificial mechanical pull on the host cell membrane triggers a signaling cascade to affect host gene expression.

SourcePLOS·JournalPLOS Biology·DateMar 21, 2005

Key target for Foot and Mouth drug revealed

Researchers at Imperial College London have solved the structure of the Foot-and-Mouth Disease Virus enzyme, revealing its atomic details and potential target for anti-viral drugs. The discovery could lead to the development of a vaccine that can be administered quickly to control outbreaks.

SourceImperial College London·JournalJournal of Biological Chemistry·DateMar 21, 2005

Alcohol relapse adversely affects 10-year liver transplant survival

A study of 54 patients with ALD who underwent liver transplants found that those who resumed alcohol consumption had significantly lower 10-year survival rates compared to abstinent patients. Higher mortality rates among relapse group were attributed to increased risk of cancers and cardiovascular events.

SourceWiley·JournalLiver Transplantation·DateMar 21, 2005